US Stock MarketDetailed Quotes
PSTV Plus Therapeutics
- 1.2300
- +0.0500+4.24%
Close Nov 25 16:00 ET
- 1.2300
- 0.00000.00%
Post 20:01 ET
7.25MMarket Cap-518P/E (TTM)
1.2500High1.1602Low115.19KVolume1.2000Open1.1800Pre Close139.06KTurnover2.22%Turnover RatioLossP/E (Static)5.90MShares2.670252wk High-1.40P/B6.38MFloat Cap1.120052wk Low--Dividend TTM5.19MShs Float7507.4985Historical High--Div YieldTTM7.61%Amplitude0.9690Historical Low1.2070Avg Price1Lot Size
Plus Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -53.40%-3.68M | 58.60%-1.15M | 22.10%-4.51M | 0.93%-12.85M | 15.80%-1.88M | 43.18%-2.4M | -5.23%-2.78M | -49.46%-5.79M | -26.19%-12.97M | 14.86%-2.23M |
| Net income from continuing operations | 10.72%-2.87M | -98.38%-2.94M | 32.13%-3.26M | 34.32%-13.32M | 32.66%-3.81M | 38.32%-3.22M | 71.94%-1.48M | -16.74%-4.81M | -51.32%-20.28M | -36.17%-5.66M |
| Operating gains losses | ---960K | ---- | ---- | --2K | --0 | --0 | --0 | --2K | ---- | ---- |
| Depreciation and amortization | 23.40%232K | 7.45%202K | -0.53%186K | 1.45%628K | -30.11%65K | -16.07%188K | 44.62%188K | 8.72%187K | 56.71%619K | -27.91%93K |
| Other non cash items | --0 | 6,596.23%3.55M | -75.76%16K | -31.70%265K | -62.03%30K | 26.09%116K | -48.54%53K | -42.11%66K | -50.89%388K | -77.99%79K |
| Change In working capital | -142.39%-156K | 255.40%2.61M | -15.76%-1.6M | -119.94%-1.12M | -47.95%1.58M | -37.73%368K | -176.09%-1.68M | -511.95%-1.38M | 352.10%5.6M | 274.75%3.03M |
| -Change in receivables | --0 | ---- | ---- | ---- | ---- | -1,208.22%-809K | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 304.66%966K | 706.00%403K | 98.82%-43K | -156.99%-3.68M | -91.46%384K | -210.28%-472K | -97.70%50K | -459.85%-3.64M | 272.09%6.45M | 241.72%4.5M |
| -Change in other current assets | -78.04%369K | 114.44%185K | -94.63%150K | 201.18%2.4M | 73.66%-793K | 1,335.90%1.68M | -2,040.91%-1.28M | 508.06%2.79M | -377.62%-2.37M | -492.72%-3.01M |
| -Change in other current liabilities | -9.68%-34K | -18.52%-32K | -6.90%-31K | 9.30%-117K | -7.14%-30K | -14.81%-31K | 30.77%-27K | 17.14%-29K | ---129K | ---28K |
| -Change in other working capital | ---1.46M | 280.30%2.05M | -231.42%-1.68M | -82.90%281K | --1.92M | --0 | ---1.14M | ---506K | --1.64M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -53.40%-3.68M | 58.60%-1.15M | 22.10%-4.51M | 0.93%-12.85M | 15.80%-1.88M | 43.18%-2.4M | -5.23%-2.78M | -49.46%-5.79M | -26.19%-12.97M | 14.86%-2.23M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 10.00%-9K | -34,463.64%-3.8M | -275.26%-364K | 78.92%-160K | -281.82%-42K | 69.70%-10K | 92.03%-11K | 83.19%-97K | -825.61%-759K | -650.00%-11K |
| Net PPE purchase and sale | -40.00%-14K | -636.36%-81K | 58.76%-40K | 68.57%-160K | 67.19%-42K | 69.70%-10K | 92.03%-11K | 53.81%-97K | -520.73%-509K | -6,500.00%-128K |
| Net intangibles purchase and sale | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---250K | --117K |
| Net investment purchase and sale | --5K | ---3.18M | ---324K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 10.00%-9K | -34,463.64%-3.8M | -275.26%-364K | 78.92%-160K | -281.82%-42K | 69.70%-10K | 92.03%-11K | 83.19%-97K | -825.61%-759K | -650.00%-11K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 624.56%6.96M | -257.40%-776K | -74.39%3.45M | -634.34%-529K | -60.81%2.52M | 359.03%961K | -93.24%493K | -34.12%13.45M | 138.37%99K |
| Net issuance payments of debt | --0 | 24.88%-302K | 0.00%-402K | 0.00%-1.61M | 0.00%-402K | 0.00%-402K | 0.00%-402K | 0.00%-402K | -482.61%-1.61M | -50.00%-402K |
| Net common stock issuance | --0 | 433.02%7.27M | -141.79%-374K | -65.89%5.4M | -82.65%221K | -57.24%2.92M | 4,296.77%1.36M | -88.37%895K | -15.22%15.83M | 12,640.00%1.27M |
| Net other financing activities | ---- | ---- | ---- | 54.98%-348K | ---- | ---- | ---- | ---- | ---773K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 624.56%6.96M | -257.40%-776K | -74.39%3.45M | -634.34%-529K | -60.81%2.52M | 359.03%961K | -93.24%493K | -34.12%13.45M | 138.37%99K |
| Net cash flow | ||||||||||
| Beginning cash position | -54.92%4.91M | -77.20%2.9M | -52.79%8.55M | -1.52%18.12M | -45.69%11.01M | -39.77%10.9M | -40.10%12.72M | -1.52%18.12M | 120.46%18.4M | -4.77%20.27M |
| Current changes in cash | -3,423.42%-3.69M | 210.01%2.01M | -4.74%-5.65M | -3,316.43%-9.57M | -14.26%-2.45M | -94.90%111K | 41.95%-1.83M | -290.10%-5.4M | -102.78%-280K | 25.49%-2.15M |
| End cash Position | -88.89%1.22M | -54.92%4.91M | -77.20%2.9M | -52.79%8.55M | -52.79%8.55M | -45.69%11.01M | -39.77%10.9M | -40.10%12.72M | -1.52%18.12M | -1.52%18.12M |
| Free cash flow | -53.34%-3.69M | 36.32%-1.78M | 22.70%-4.55M | 5.24%-13.01M | 14.34%-1.92M | 43.38%-2.41M | -0.40%-2.79M | -32.27%-5.89M | -31.72%-13.73M | 14.77%-2.25M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data